{"id":36944,"date":"2025-09-24T10:27:20","date_gmt":"2025-09-24T08:27:20","guid":{"rendered":"https:\/\/www.transgene.com\/?p=36944"},"modified":"2025-10-14T11:20:47","modified_gmt":"2025-10-14T09:20:47","slug":"onglet-cp","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/onglet-cp\/","title":{"rendered":"onglet cp"},"content":{"rendered":"\n<div id=\"ongletCP\" class=\"wp-block-uagb-container uagb-layout-grid uagb-block-36c4ca29 alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\">\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<div id=\"ancre-cp\" class=\" eplus-wrapper\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-36965\" style=\"max-width: 50px; margin: 20px 0 0 20px;\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/scroll.jpg\" alt=\"\" width=\"145\" height=\"143\" \/> <ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261109_Q32026_FR.pdf\" title=\"Transgene poursuit ses programmes cliniques et fait le point sur sa situation financi\u00e8re au troisi\u00e8me trimestre 2026\"><div class='catlistdate'>9 novembre 2026<\/div>  <div class='catlistTitle'>Transgene poursuit ses programmes cliniques et fait le point sur sa situation financi\u00e8re au troisi\u00e8me trimestre 2026<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261105_IST_BT001_FR.pdf\" title=\"Premier patient trait\u00e9 dans un essai de Phase 1 \u00e9valuant BT-001 de Transgene et BioInvent dans le cancer du rectum\"><div class='catlistdate'>5 novembre 2026<\/div>  <div class='catlistTitle'>Premier patient trait\u00e9 dans un essai de Phase 1 \u00e9valuant BT-001 de Transgene et BioInvent dans le cancer du rectum<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261103_SITCAbstract_FR.pdf\" title=\"Transgene pr\u00e9sentera des donn\u00e9es pr\u00e9cliniques au SITC 2026 sur son virus oncolytique innovant ouvrant la voie \u00e0 une administration syst\u00e9mique\"><div class='catlistdate'>3 novembre 2026<\/div>  <div class='catlistTitle'>Transgene pr\u00e9sentera des donn\u00e9es pr\u00e9cliniques au SITC 2026 sur son virus oncolytique innovant ouvrant la voie \u00e0 une administration syst\u00e9mique<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261005_SITC_Title_FR.pdf\" title=\"Transgene pr\u00e9sentera un poster sur les donn\u00e9es pr\u00e9cliniques de son virus oncolytique innovant au SITC 2026\"><div class='catlistdate'>5 octobre 2026<\/div>  <div class='catlistTitle'>Transgene pr\u00e9sentera un poster sur les donn\u00e9es pr\u00e9cliniques de son virus oncolytique innovant au SITC 2026<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261001_InvestorAccess_FR.pdf\" title=\"Transgene participera \u00e0 l&rsquo;Investor Access\"><div class='catlistdate'>1<sup>er<\/sup> octobre 2026<\/div>  <div class='catlistTitle'>Transgene participera \u00e0 l&rsquo;Investor Access<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260924_RFS26_FR.pdf\" title=\"Transgene \u00e9tend sa plateforme myvac\u00ae, et s&rsquo;affirme comme acteur cl\u00e9 dans un domaine en pleine \u00e9mergence des immunoth\u00e9rapies individualis\u00e9es contre le cancer\"><div class='catlistdate'>24 septembre 2026<\/div>  <div class='catlistTitle'>Transgene \u00e9tend sa plateforme myvac\u00ae, et s&rsquo;affirme comme acteur cl\u00e9 dans un domaine en pleine \u00e9mergence des immunoth\u00e9rapies individualis\u00e9es contre le cancer<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260908_PBG_TG_FR.pdf\" title=\"Transgene \u00e9tend son partenariat strat\u00e9gique avec ProBioGen par un nouvel accord de licence pour la lign\u00e9e cellulaire AGE1.CR.pIX et publient les r\u00e9sultats de la Phase 1 dans Nature Communications\"><div class='catlistdate'>8 septembre 2026<\/div>  <div class='catlistTitle'>Transgene \u00e9tend son partenariat strat\u00e9gique avec ProBioGen par un nouvel accord de licence pour la lign\u00e9e cellulaire AGE1.CR.pIX et publient les r\u00e9sultats de la Phase 1 dans Nature Communications<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260902_TG4050_NatCom_FR.pdf\" title=\"Transgene et NEC annoncent 100 % de survie sans r\u00e9cidive apr\u00e8s 3 ans de suivi avec TG4050 et publient les r\u00e9sultats de la Phase 1 dans Nature Communications\"><div class='catlistdate'>2 septembre 2026<\/div>  <div class='catlistTitle'>Transgene et NEC annoncent 100 % de survie sans r\u00e9cidive apr\u00e8s 3 ans de suivi avec TG4050 et publient les r\u00e9sultats de la Phase 1 dans Nature Communications<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260625_TGMVA_data_FR.pdf\" title=\"Transgene pr\u00e9sente des donn\u00e9es pr\u00e9cliniques de son vaccin innovant contre le mpox produit sur lign\u00e9e cellulaire, TG-MVA\"><div class='catlistdate'>25 juin 2026<\/div>  <div class='catlistTitle'>Transgene pr\u00e9sente des donn\u00e9es pr\u00e9cliniques de son vaccin innovant contre le mpox produit sur lign\u00e9e cellulaire, TG-MVA<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260622_TG4070_FR.pdf\" title=\"Transgene \u00e9tend sa plateforme myvac\u00aeavec TG4070, un vaccin th\u00e9rapeutique individualis\u00e9 dans le cancer du poumon non \u00e0 petites cellules\"><div class='catlistdate'>22 juin 2026<\/div>  <div class='catlistTitle'>Transgene \u00e9tend sa plateforme myvac\u00aeavec TG4070, un vaccin th\u00e9rapeutique individualis\u00e9 dans le cancer du poumon non \u00e0 petites cellules<\/div><\/a><\/li><\/ul><\/div>\n\n\n\n<h4 class=\" wp-block-heading eplus-wrapper\"><a class=\"arrow-tgo5\" href=\"..\/press-releases\/\">voir tous les communiqu\u00e9s de presse <br> &nbsp;<\/a><\/h4>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\">&nbsp;<\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>voir tous les communiqu\u00e9s de presse &nbsp; &nbsp;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[112],"tags":[],"class_list":["post-36944","post","type-post","status-publish","format-standard","hentry","category-investisseurs","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"voir tous les communiqu\u00e9s de presse &nbsp; &nbsp;","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/36944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=36944"}],"version-history":[{"count":3,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/36944\/revisions"}],"predecessor-version":[{"id":38303,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/36944\/revisions\/38303"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=36944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=36944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=36944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}